Xenon Pharma grants 32,758 inducement stock options, 19,013 RSUs to new hires
XENE•Inducement awards to new hires
Xenon Pharmaceuticals granted inducement equity awards to 11 new non-officer employees, totaling 32,758 share options and 19,013 RSUs.
- Options carry a $64.19 exercise price, matching the July 30, 2026 closing price; each option has a 10-year term.
- Options vest over four years: 25% after one year from each employee’s start date, then monthly for the remaining balance.
- RSUs vest 25% on each of the first four anniversaries of the July 30, 2026 grant date.
Related News
Carlyle Alpinvest Private Markets Fund To Repurchase Aggregate Amount Of Class A, Class W, Class I & Class X Shares Up To 5% Of Total Net Assets
CG•
Bunker Hill Mining Q2 FY26 net income falls to $18.19 million; operating expenses rise to $4.42 million
BHLL•
